RxDoctor Payments Data

Alyssa Bijeaux, APRN

Family · Oakdale, LANPI 1992396089

Payments from drug & device makers

$566in general payments, 2019–2025

Across 26 payments — averaging $21.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Supernus Pharmaceuticals, Inc.$196
  • AbbVie$109
  • Ironshore Pharmaceuticals Inc.$50
  • Vanda Pharmaceuticals Inc.$37
  • Novo Nordisk$30
  • Lilly USA, LLC$28
  • plus $117 from 6 others

What the payments were for

  • Food & beverage$566100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$566 in reported general payments places this provider in the 50th percentile of 3,610 family providers in Louisiana.

See all family providers in Louisiana

Medicare billing

Part B allowed, 2024
$538
Medicare patients
30
Services billed
58

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide58$63,688
OzempicSemaglutide14$12,522
JanumetSitagliptin Phos/Metformin Hcl12$11,623
RybelsusSemaglutide12$11,455
LinzessLinaclotide13$6,757
GemtesaVibegron14$6,689
SymbicortBudesonide/Formoterol Fumarate24$5,967
Combivent RespimatIpratropium/Albuterol Sulfate11$5,173
Lantus SolostarInsulin Glargine,hum.Rec.Anlog16$2,295
Albuterol Sulfate HfaAlbuterol Sulfate45$1,438
SynthroidLevothyroxine Sodium13$954
Gabapentin86$920
Ezetimibe80$891
Montelukast Sodium137$883
Butorphanol Tartrate21$842

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$28$63,68858 claims
Novo NordiskOzempic, Rybelsus$30$23,97726 claims
AbbVieLinzess, Synthroid$109$7,71226 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 3,610 family providers in Louisiana.

Other family in Oakdale

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →